Development of congestive heart failure in Japanese patients with atrial fibrillation

Circulation Journal

Volumn 71, Issue 3, 2007, Pages 308-312

  Fukuda, Taira ^a   Yamashita, Takeshi ^a   Sagara, Kouichi ^a   Kato, Takeshi ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Atrial fibrillation; Congestive heart failure; Hypertrophy

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS;

AGED; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; JAPAN; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS;

EID: 33947110316     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.308     Document Type: Article

References (23)

1. Go AS, Hylek EM, Philips KA, Chang Y, Renault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983; 106: 389-396.
3. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigatiors. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
4. Haldman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137: 352-360.
5. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844.
6. Lee SH, Jung JH, Choi SH, Lee N, Park WJ, Oh DJ, et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 2006; 70: 100-104.
7. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999; 100: 87-95.
8. Shmbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997; 29: 709-715.
9. Banach M, Rysz J, Drozdz JA, Okonski P, Misztal M, Barylski M, et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: A preliminary report. Circ J 2006; 70: 438-441.
10. Koitabashi T, Inomata T, Niwano S, Nishi M, Takeuchi I, Nakano H, et al. Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 2005; 69: 823-830.
11. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
12. O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ Jr, Philippon F, Sami M, et al; AFFIRM Investigators. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). Am J Cardiol 2005; 96: 815-821.
13. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings. Circulation 1987; 75: 565-572.
14. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20: 1180-1186.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187-220.
17. Katoh T, Iinuma H, Inoue H, Ohe T, Ogawa S, Kasanuki H, et al. Multicenter prospective nonrandomized study of long-term antiarrhythmic drug therapy in patients with tachyarrhythmias: Japanese Antiarrhythmic Long-Term Study-2 (JALT-2 Study). Jpn Circ J 2001; 65: 275-278.
18. Jaime Caro J, Flegel KM, Orejuela M, Kelley HE, Speckman JL, Migliaccio-Walle K. anticoagulant prophylaxis against stroke in atrial fibrillation: Effectiveness in actual practice. Can Med Assoc J 1999; 161: 4933-4997.
19. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, et al. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. Circulation 1999; 99: 3028-3035.
20. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
21. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, et al; LIFE Study Investigators. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Circulation 2006; 113: 67-73.
22. Grigorian Shamagian L, Roman AV, Seara JG, Sande JL, Veloso PR, Gonzalez-Juanatey JR. Atrial fibrillation in patients hospitalized for congestive heart failure: The same prognostic influence independently of left ventricular systolic function? Int J Cardiol 2006; 110: 366-372.
23. Keating RJ, Gersh BJ, Hodge DO, Weivoda PL, Patel PJ, Hammill SC, et al. Effect of atrial fibrillation pattern on survival in a community-based cohort. Am J Cardiol 2005; 96: 1420-1424.